Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas
Crossref DOI link: https://doi.org/10.1007/s11060-015-1745-x
Published Online: 2015-02-22
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Minniti, Giuseppe
Agolli, Linda
Falco, Teresa
Scaringi, Claudia
Lanzetta, Gaetano
Caporello, Paola
Osti, Mattia Falchetto
Esposito, Vincenzo
Enrici, Riccardo Maurizi
Text and Data Mining valid from 2015-02-22